Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 2Recurrence 1Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × gallium nitrate × Clear all
NCT00002578 2015-10-06

Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Roswell Park Cancer Institute

Phase 2 Completed
35 enrolled
Lymphoid

Lymphoma

NCT00054808 2006-02-08

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

Genta Incorporated

Phase 2 Completed
40 enrolled
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡